Just a few years ago, Xarelto was being hailed as more than just an up and coming blood thinner. It was the only alternative to Coumadin. For many, it would mean fewer restrictions on their life since Xarelto didn’t require the same blood tests. However, releasing the drug onto the market was an extremely dangerous move taken by Janssen Pharmaceuticals,
Xarelto, one of the newest blood thinners on the market, is under fire. The number of lawsuits against Janssen Pharmaceuticals and Bayer, the manufacturers, have recently increased. There are currently more than 3,000 lawsuits filed against the manufacturers. Lawsuits allege that the manufacturers misled the public and ignored the FDA. Thousands of patients have filed lawsuits alleging excessive bleeding and
As of July 2016, almost 7,000 Xarelto lawsuits were filed against Bayer and Janssen Pharmaceuticals. Xarelto is one of the newest blood thinners out on the market. The problem with Xarelto is found in its side effects. Like other blood thinners, Xarelto carries the risk of uncontrolled bleeding. However, unlike other blood thinners, Xarelto does not have a known antidote
Bayer/Johnson & Johnson and Jannsen Pharmaceutical Research have been named as defendants in lawsuits regarding Xarelto. The lawsuits are seeking compensation for injuries arising from complications due to rivaroxaban. Rivaroxaban is the active ingredient in Xarelto and is used to prevent blood clots. Unfortunately, serious and sometimes life-threatening complications and side effects have been linked to the use of Xarelto.
Xarelto, a new type of anticoagulant (blood thinner), was developed as a more convenient alternative to Coumadin, a blood thinner containing warfarin. Also known as rivaroxaban, Xarelto received FDA approval in 2011. However, many patients taking the medication soon began experiencing severe side effects, primarily uncontrolled bleeding. Recent reports indicate that a device used to measure bleeding complications during Xarelto’s